McDermott Will & Emery and E+H Rechtsanwälte advise Ligand Pharmaceuticals Incorporated on the deal. Ligand Pharmaceuticals Incorporated announced the acquisition of all shares in the Austrian...
Ligand Pharmaceuticals’ Acquisition of APEIRON Biologics
Ligand’s Spin-off of OmniAb Business
Latham & Watkins represented Ligand in the transaction, while Weil, Gotshal & Manges represented APAC. Ligand Pharmaceuticals Incorporated has announced the signing of a definitive merger...